KIDNEY TRANSPLANTATION
- Coronary artery disease in renal transplant recipients
Screening for coronary artery disease before transplantation can identify high -risk patients and save lives and money.
- Azathioprine vs cyclosporine in recipients of HLA-identical renal allografts
These two agents produce equally satisfactory outcomes in this immunologically favored group. The need for continued steroid therapy in these patients requires further study.
- Initial studies with FK506 in renal transplantation
Advantages of this immunosuppressive agent include relatively few side effects and high potency, eliminating the need for steroids in some patients.